AdventHealth
Oncology
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New Treatments
FEATURING
Guru Sonpavde
- 634 views
- April 16, 2024
- 3
AdventHealth
FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advanced Urothelial Carcinoma
FEATURING
Guru Sonpavde
- 257 views
- March 11, 2024
- 1
Insights from 2024 ASCO® GU Annual Meeting
ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Carcinoma"
FEATURING
Guru Sonpavde
- 362 views
- February 6, 2024
- 7
Insights from 2023 ESMO Annual Meeting
ESMO23 Highlights in Urothelial Carcinoma
FEATURING
Guru Sonpavde,
Bradley McGregor
- 232 views
- November 28, 2023
- 1
Insights from 2023 ESMO Annual Meeting
Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting EV302 and CheckMate 901
FEATURING
Guru Sonpavde
- 816 views
- October 30, 2023
- 2
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Key Bladder Cancer/Urothelial Carcinoma Updates"
FEATURING
Guru Sonpavde
- 368 views
- June 16, 2023
- 2
ESMO 2022 Conference Coverage
ESMO 2022: Key Bladder Cancer/Urothelial Carcinoma Presentations
FEATURING
Guru Sonpavde
- 802 views
- September 16, 2022
- 1
SABCS 2022 Conference Coverage
Adjuvant Treatment for HR+/HER2-, Node-Positive, High-Risk eBC: 4-Year Results From the monarchE Study
FEATURING
Wassim Mchayleh
- 296 views
- February 7, 2023
- 1